Analysis of Orphan Drugs P&R criteria in Spain (2003-2019)

//Analysis of Orphan Drugs P&R criteria in Spain (2003-2019)

Analysis of Orphan Drugs P&R criteria in Spain (2003-2019)

Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019

Avaliable at: https://ojrd.biomedcentral.com/articles/10.1186/s13023-020-01507-4

2020-09-23T17:52:11+00:00August 28th, 2020|Articles|

Leave A Comment

This website uses cookies so that you have the best user experience. If you continue browsing you are giving your consent for the acceptance of the aforementioned cookies and the acceptance of our cookies policy, Click on the link for more information. ACEPTAR

Aviso de cookies